|
⚲
|
| Keyboard |
| Paul Grint | |
|---|---|
| Firm | |
| Address | 8949 Kenamar Drive Ste 101 San Diego, CA 92121 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Synedgen Inc | 021-525514 | Director | 1.8 M of 2.0 M |
||
| Inhibikase Therapeutics Inc | 021-515107 | Director | of 8.0 M |
||
| Crisprqc Inc | 021-506176 | Director | 3.9 M of 10.0 M |
||
| Codagenix Inc | 021-474366 | Director | 25.0 M of 25.0 M |
||
| Cardea Bio Inc | 021-375960 | Director | 1.7 M of 9.2 M |
||
| Amplyx Pharmaceuticals Inc | 021-291889 | Director | 91.3 M of 102.7 M |
||
| Synedgen Inc | 021-273974 | Director | 3.0 M of 3.5 M |
||
| Synedgen Inc | 021-262123 | Director | 6.0 M of 6.5 M |
||
| Numira Biosciences Inc | 021-126154 | Director | 3.3 M of 3.3 M |
||